4D Molecular Therapeutics, Inc.
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
FDMT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US35104E1001
- LEI:
- Country:
- United States of America
- Address:
- 5858 HORTON STREET #455, 94608 EMERYVILLE
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
4D Molecular Therapeutics (4DMT) is a clinical-stage genetic medicines company dedicated to developing transformative therapies for large market diseases. The company's core innovation is its proprietary Therapeutic Vector Evolution platform, which harnesses the power of directed evolution to invent customized and optimized adeno-associated virus (AAV) vectors. These proprietary vectors are engineered for targeted and efficient delivery of genetic payloads to specific tissues. 4DMT's product development pipeline is initially focused on creating treatments for serious unmet medical needs in the fields of ophthalmology, pulmonology, and cardiology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all 4D Molecular Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 4D Molecular Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 4D Molecular Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
